Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Conmed Corporation (CNMD:NYSE), powered by AI.
Conmed Corporation is currently trading at $34.57. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Conmed Corporation on Alpha Lenz.
Conmed Corporation's P/E ratio is 22.8.
“Conmed Corporation trades at a P/E of 22.8 (fair value) with modest ROE of 4.7%.”
Ask for details →Conmed Corporation is a global medical technology company specializing in the development and supply of surgical devices and equipment. Its primary function is to provide innovative surgical solutions in areas such as orthopedics, general surgery, gynecology, and gastroenterology. Conmed's product portfolio encompasses advanced surgical tools, including energy systems, minimally invasive instrumentation, and orthopedic surgical equipment. As a prominent player in the healthcare and medical devices industry, Conmed impacts the way surgical procedures are performed, emphasizing patient safety and improved clinical outcomes. Headquartered in Utica, New York, the company serves a diverse customer base that includes hospitals, surgical centers, and healthcare professionals worldwide. Conmed's commitment to research and development, alongside strategic acquisitions and partnerships, strengthens its position in the marketplace, ensuring that it continues to meet the evolving demands of modern surgical practices.
“Conmed Corporation trades at a P/E of 22.8 (fair value) with modest ROE of 4.7%.”
Ask for details →Conmed Corporation (ticker: CNMD) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 3,900 employees. Market cap is $1.1B.
The current price is $34.57 with a P/E ratio of 22.8x and P/B of 1.04x.
ROE is 4.72% and operating margin is 7.46%. Annual revenue is $1.4B.